Valuation MannKind Corporation

Stocks

Market Closed - Nasdaq 00:00:00 24/09/2026 +04			5-day change	1st Jan Change
3.340 ^USD	-4.30%		-5.92%	-41.09%

09-09	MannKind Corporation and Rose Pharma Inc Enter Licensing and Collaboration Agreement to Develop Inhaled Rapid-Acting, Short-Duration GLP-1 for Weight Management	CI
09-09	MannKind, Rose Pharma Sign Deal to Develop Weight-Management Drug	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	1,098	1,387	981.3	1,773	1,741	1,074	-	-
Change	-	26.33%	-29.26%	80.71%	-1.81%	-38.32%	-	-
Enterprise Value (EV)	1,098	1,387	679	1,773	1,741	1,074	1,074	1,074
Change	-	26.33%	-51.05%	161.16%	-1.81%	-38.32%	0%	0%
P/E	-13.7x	-15.5x	-91x	64.3x	284x	-18.3x	-2,672x	127x
PBR	-	-	-	-	-	-	-	-
PEG	-	-2.48x	1x	-0x	-3.6x	0x	26.9x	-0x
Capitalization / Revenue	14.6x	13.9x	4.93x	6.21x	4.99x	2.42x	2.13x	2.08x
EV / Revenue	0x	0x	0x	0x	0x	2.42x	2.13x	2.08x
EV / EBITDA	-	-	-	-	-	-	-	-
EV / EBIT	-0x	-0x	0x	0x	0x	104x	22x	21.3x
EV / FCF	-	-	-0x	0x	0x	53.7x	15.8x	48.8x
FCF Yield	-	-	-0.85%	1.85%	0.79%	1.86%	6.33%	2.05%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-0.32	-0.34	-0.04	0.1	0.02	-0.1825	-0.00125	0.0262
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	75.44	99.77	199	285.5	349	443.4	504	517.3
EBITDA	-	-	-	-	-	-	-	-
EBIT ¹	-47.02	-64.11	8.678	72.59	38.8	10.28	48.88	50.35
Net income ¹	-80.93	-87.4	-11.94	27.59	5.863	-57.18	0.0271	10.08
Net Debt	-	-	-302.3	-	-	-	-	-
Reference price ²	4.370	5.270	3.640	6.430	5.670	3.340	3.340	3.340
Nbr of stocks (in thousands)	251,256	263,196	269,575	275,778	307,070	321,541	-	-
Announcement Date	24/02/22	23/02/23	27/02/24	26/02/25	26/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
MANNKIND CORPORATION	-19.12x	-	-	-	1.07B
WUXI APPTEC CO., LTD.	21.8x	7.74x	15.55x	1.36%	74.18B
ARGENX SE	31.81x	9.18x	28.6x	0.04%	59.55B
INSMED INCORPORATED	-73.75x	14.26x	-68.76x	-.--%	25.84B
BIONTECH SE	-15.46x	5.96x	-7.5x	-.--%	24.73B
GENMAB A/S	28.48x	5.36x	17.82x	-.--%	20.87B
PHARMAESSENTIA CORPORATION	43.75x	16.03x	32.53x	0.34%	15.32B
EXELIXIS, INC.	17.96x	5.35x	12.5x	-.--%	14.06B
SUMMIT THERAPEUTICS INC.	-14.82x	3341.5x	-17.09x	-.--%	13.12B
MADRIGAL PHARMACEUTICALS, INC.	-82.17x	7.51x	-62.2x	-.--%	11.85B
Average	-6.15x	379.21x	-5.39x	0.19%	26.06B
Weighted average by Cap.	5.95x	177.28x	3.77x	0.42%